It appears that your browser has cookies disabled.
The website requires your browser to enable cookies in order to login.
Please enable cookies and reload this page.
Advancing Cancer Diagnostics, Improving Lives
Select Your Country/Region
Your location doesnt match the address (URL), do you want to change it?
Each country/region may have its own set of regulatory requirements and medical practices. The information found on each country version of our website is specific to and applicable for only that country/region. This includes (but is not limited to) all product details/availability, documentation, pricing, and promotions.
Hybridization of TERT / 5q31 Probe to a tissue section showing gain of the TERT region.
Hybridization of TERT / 5q31 Probe to a tissue section showing gain of the TERT region.
IVD TERT/5q31 (tissue)
Amplifications of the TERT gene at 5p15 has been observed in a variety of cancers, particularly lung cancer, cervical tumors, and breast carcinomas. Several studies have revealed a high frequency of TERT gene amplification in human tumors, which indicates that the TERT gene may be a target for amplification during the transformation of human malignancies and that this genetic event probably contributes to a dysregulation of TERT/ telomerase occurring in a subset of human tumors. The TERT (5p15) FISH probe is designed as a dual-color assay to detect amplification at 5p15. The CDC25C/EGR1 (5q31) gene region probe is included as internal control.
References: Bryce et al, 2000, Neoplasia, 2;197-201. Zhang et al, 2000, Cancer Res, 60;6230-6235.
